Advancements in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Treatment: Utilizing Fas-FasL Inhibition to Target Cell Death Signaling Pathways for Practical Human Application.

Saito, Yuki; Lotti, Roberta; Kimura, Haruna; Hasegawa, Akito; Bennett, Brydon; Amato, Antonino; Pincelli, Carlo; Abe, Riichiro

Saito, Yuki; Lotti, Roberta; Kimura, Haruna; Hasegawa, Akito; Bennett, Brydon; Amato, Antonino; Pincelli, Carlo; Abe, Riichiro.

Afiliação

Saito Y; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Lotti R; PinCell srl, Milano, Italy; DermoLab, University of Modena and Reggio Emilia, Modena, Italy.
Kimura H; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Hasegawa A; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.
Bennett B; PinCell srl, Milano, Italy.
Amato A; PinCell srl, Milano, Italy.
Pincelli C; PinCell srl, Milano, Italy. Electronic address: carlo.pincelli@unimore.it.
Abe R; Division of Dermatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan. Electronic address: aberi@med.niigata-u.ac.jp.

J Invest Dermatol ; 2024 Sep 19.

Article em En | MEDLINE | ID: mdl-39303908

Palavras-chave

Cell death; FasL; StevensJohnson syndrome; Toxic epidermal necrolysis

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Invest Dermatol Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Japão

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google